Considerations about bisphosphonate therapy and patients using dental prosthesis: a literature review

Ananda da Silva Maganhoto; Túlio Garcia Margute; Thiago  Quirino Mota da Silva; Andrei Rabenschlag Rossato; Igor  Fonseca dos Santos; Tiago Garcia Margute

doi:10.52600/2763-583X.bjcr.2021.1.3.103-115

PDF

Published: Aug 9, 2021

DOI: https://doi.org/10.52600/2763-583X.bjcr.2021.1.3.103-115

Keywords:

Bisphosphonates, Osteonecrosis, Dental prosthesis

Ananda da Silva Maganhoto

Centro Universitário Ingá - Uningá

Túlio Garcia Margute

Universidade Luterana do Brasil - Ulbra

Thiago Quirino Mota da Silva

Universidade CEUMA

Andrei Rabenschlag Rossato

Faculdade São Leopoldo Mandic

Igor Fonseca dos Santos

Universidade de Gurupi - UNIRG

Tiago Garcia Margute

Universidade Guarulhos - UNG

Abstract

Bisphosphonates are drugs used for treatment of many medical diseases; their prescription has increased over the years due to the various indications for use. They come in two distinct groups: containing nitrogen (alendronate, ibandronate, pamidronate, risedronate and zolendronate) and without nitrogen in their composition (etidronate and tiludronate). Despite being used in the treatment of several diseases, they can lead to the development of osteonecrosis in the patient's maxilla and/or mandible, when submitted to dental procedures, such as extractions, surgeries or traumas for non-adapted prostheses. It is recommended that patients who use bisphosphonates visit the dentist at least once a year, for better control and monitoring of oral health.

How to Cite

da Silva Maganhoto, A., Garcia Margute, T., Quirino Mota da Silva, T. ., Rabenschlag Rossato, A., Fonseca dos Santos, I. ., & Garcia Margute, T. (2021). Considerations about bisphosphonate therapy and patients using dental prosthesis: a literature review. Brazilian Journal of Case Reports, 1(3), 103–115. https://doi.org/10.52600/2763-583X.bjcr.2021.1.3.103-115

Issue

Vol. 1 No. 3 (2021): July/September - 2021

Section

Health Review

This work is licensed under a Creative Commons Attribution 4.0 International License.

Author Biographies

Ananda da Silva Maganhoto, Centro Universitário Ingá - Uningá

Centro Universitário Ingá - Uningá, Maringá, Paraná, PR, Brazil.

Túlio Garcia Margute, Universidade Luterana do Brasil - Ulbra

Universidade Luterana do Brasil - Ulbra, Torres, Rio Grande do Sul, RS, Brazil

Thiago Quirino Mota da Silva, Universidade CEUMA

Universidade CEUMA, São Luis, Maranhão, MA, Brazil.

Andrei Rabenschlag Rossato, Faculdade São Leopoldo Mandic

Faculdade São Leopoldo Mandic, Campinas, São Paulo, SP, Brazil.

Igor Fonseca dos Santos, Universidade de Gurupi - UNIRG

Universidade de Gurupi - UNIRG, Gurupi, Tocantins, TO, Brazil.

Tiago Garcia Margute, Universidade Guarulhos - UNG

Universidade Guarulhos - UNG, Guarulhos, São Paulo, SP, Brazil.

References

Castro LF, Silva ATA, Chung MC, Ferreira AG, Ferreira EI. Bifosfonatos (BFs) coma transportadores osteotrópicos no planejamento de farmacos dirigidos. Quimica Nova. 2004, 27;(3):456-460.

Marx RE, Cillo JE, Ulloa JJ. Oral Bisphosphonate-lnduced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment. Journal of Oral and Maxillofacial Surgery. 2007,65(12);2397-2410.

Dannemann C, Grätz KW, Riener MO, Zwahlen RA. Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone. 2007 Apr;40(4):828-34. doi: 10.1016 / j.bone.2006.11.023.

Pazianas M, Cooper C, Ebetino FH, Russell RG. Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis. Ther Clin Risk Manag. 2010 Jul 21;6:325-43. doi: 10.2147/tcrm.s8054.

Scarpa L, Leite LCM, Lacerda JCT. de, Arantes DCB. Osteonecrose nos ossos da maxila e mandíbula associada ao uso do bifosfonato de sódio. Revista Brasileira De Pesquisa Em Saúde/Brazilian Journal of Health Research. 2010,12(1).

Izquierdo CM, Oliveira MG, Weber JBB. Terapeutica com bisfosfonatos: implicagoes no paciente odontol6gico - revisao de literatura. RFO. 2011, 16(3):347-352.

de-Freitas NR, Lima LB, de-Moura MB, Veloso-Guedes CC, Simamoto-Júnior PC, de-Magalhães D. Bisphosphonate treatment and dental implants: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21(5):e644-51. doi: 10.4317/ medoral.20920.

Brunton L, Lazo J, Parker K. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11. ed. New York: Goodman, 2011. 2084 p.

Russell RG. Bisphosphonates: mode of action and pharmacology. Pediatrics. 2007 Mar;119 Suppl 2:S150-62. doi: 10.1542/peds.2006-2023H.

Netto HDMC, Lisboa RB, Ortega RL, Mazzonetto R. Osteonecrose mandibular ap6s terapia por implantes osseointegrados decorrente do uso do bifosfonato: revisão de literatura e relato de caso. lmplantnews.2007, 4:427-30.

Assael LA. New foundations in understanding osteonecrosis of the jaws. J Oral Maxillofac Surg. 2004 Feb;62(2):125-6. doi: 10.1016 / j.joms.2003.11.009.

Bortolini MP. Bisfosfonatos na Odontologia. 2009. 42 f. Monografia (Especialização) - Curso de Especialização em lmplantodontia, Odontologia, Universidade Tuiuti do Parana, Curitiba, 2009.

American Dental Association Council on Scientific Affairs - ADA. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. The Journal of the American Dental Association, 2006;137(8), p. 1144-1150.

Braun E, Iacono VJ. Bisphosphonates: a review of pharmacology and implications for patient management. Perio Clin Investig. 2005;1:1-20.

Senel FC, Saracoglu Tekin U, Durmus A, Bagis B. Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case. J Oral Maxillofac Surg. 2007 Mar;65(3):562-5. doi: 10.1016/j.joms.2006.10.043.

Maahs, MAP. Associa ao entre o uso de bisfosfonatos e osteonecrose dos maxilares: estudo em ratos. 2008. 89 f. Tese (Doutorado) - Curso de Doutorado em Estomatologia Clinica, Odontologia, Universidade Cat6Iica do Rio Grande do Sul, Porto Alegre, 2008.

Martins MAT, Giglio AD, Martins MD, Pavesi VCS, Lascala CA. Osteonecrose dos maxilares associada ao uso de bisfosfonatos: importante complicação do tratamento oncológico. Rev Bras Hematol, 2009; 31(1):41-46.

Badros A, Weikel D, Salama A, Goloubeva O, Schneider A, Rapoport A, Fenton R, Gahres N, Sausville E, Ord R, Meiller T. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol. 2006 Feb 20;24(6):945-52. doi: 10.1200/JCO.2005.04.2465.

Chaudhry AN, Ruggiero SL. Osteonecrosis and bisphosphonates in oral and maxillofacial surgery. Oral Maxillofac Surg Clin North Am. 2007 May;19(2):199-206, vi. doi: 10.1016/j.coms.2007.01.005.

Fernandes C, Leite RS, Lanças FM. Bisfosfonatos: Sintese, Análises químicas e aplicações farmacológicas. Quim. Nova. 2005, 28(2):274-280.

Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003 Sep;61(9):1115-7. doi: 10.1016/s0278-2391(03)00720-1.

Caldas RJ, Pontes JRM, Antunes HS. Osteonecrose dos maxilares induzida par bisfosfonatos: relato de caso clinico. Revista Brasileira de Cancerologia, 2009;55(2):151-155.

Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol. 2010 Aug;136(8):1117-24. doi: 10.1007/s00432-010-0907-7.

Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. 0 tratamento de pacientes com osteonecrose associada aos bifosfonatos: uma tomada de posigao da Academia Americana de Medicina Oral. JADA.2006;6(3):16.

Melo AC, Bastos M, Bastos MR, Loureiro AS, Araújo SS. Osteonecrose da mandibula em paciente portador de mieloma multiple: patologia secundaria ao uso do pamidronato. Revista Brasileira de Hematologia e Hemoterapia. 2005;27(3):221-222.

Bagan JV, Jimenez Y, Murillo J, Hernandez S, Poveda R, Sanchis JM, Diaz JM, Scully C. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol. 2006 Mar;42(3):327-9. doi: 10.1016 / j.oraloncology.2005.08.001. [30] Mehrotra B, Ruggiero SL. Bisphosphonate related osteonecrosis (BRON) of the jaw: single institutional update. Blood. 106: 291, 2005.

Holzinger D, Seemann R, Klug C, Ewers R, Millesi G, Baumann A, Wutzl A. Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs). Oral Oncol. 2013 Jan;49(1):66-70. doi: 10.1016/j.oraloncology.2012.07.008.

Assael LA. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies. J Oral Maxillofac Surg. 2009 May;67(5 Suppl):35-43. doi: 10.1016/j.joms.2009.01.003.

Neville BW, et al. Patologia oral e maxilofacial. 3 ed. Rio de Janeiro: Elsevier, 2009.

Rogers SN, Hung J, Barber AJ, Lowe D. A survey of consultant members of the British Association of Oral and Maxillofacial Surgeons regarding bisphosphonate-induced osteonecrosis of the jaws. Br J Oral Maxillofac Surg. 2009 Dec;47(8):598-601. doi: 10.1016/j.bjoms.2009.07.020.

Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg. 2010 Apr;68(4):790-6. doi: 10.1016 / j.joms.2009.09.017.

Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Toyosawa S, Nagata T, Urade M. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab. 2010 Jul;28(4):365-83. doi: 10.1007/s00774-010-0162-7.

Wutzl A, Pohl S, Sulzbacher I, Seemann R, Lauer G, Ewers R, Drach J, Klug C. Factors influencing surgical treatment of bisphosphonate-related osteonecrosis of the jaws. Head Neck. 2012 Feb;34(2):194-200. doi: 10.1002/hed.21708.

Bauer JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S. Awareness and education of patients receiving bisphosphonates. J Craniomaxillofac Surg. 2012 Apr;40(3):277-82. doi: 10.1016/j.jcms.2011.04.011.

Vescovi P, Merigo E, Meleti M, Manfredi M, Guidotti R, Nammour S. Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients. J Oral Pathol Med. 2012 Mar;41(3):214-21. doi: 10.1111 / j.1600-0714. 2011. 01091.x.

Mozzati M, Arata V, Gallesio G. Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos Int. 2013 May;24(5):1707-12. doi: 10.1007/s00198-012-2239-8.

Silva LG, Goldenberg M. A mastigação no processo de envelhecimento. Revista CEFAC. 2001;3:27-35.

Fajardo RS, Neto CLMM, Santos DM, Goiato MC. Analise das condições funcionais e psicol6gicas em pacientes edentulos portadores de pr6teses totais. Arq Odontol.2002;38(2):87-94.

Fazito LT, Perim JV, Di Ninno CQMS. Comparação das queixas alimentares de idosos com e sem pr6tese dentaria. Rev CEFAC. 2004;6(2):143-150.

Zanata A, Felin GC, De Bona MC, Sawazaki R, De Conto F. Osteonecrose mandibular associada ao uso de bisfosfonato de s6dio em paciente com mieloma multiple. Revista Portuguesa de Estomatologia, Medicina Dentaria e Cirurgia Maxilofacial. 2014;55(2):115- 120.

Gegler A, Cherubini K, Figueiredo MAZ, Yurgel LS, Azambuja AA. Bisfosfonatos e osteonecrose maxilar: revisao da literatura e relato de dais casos. Revista Brasileira de Cancerologia. 2006;52(1):25- 31.

Dotto ML, Dotto AC. Osteonecrose dos maxilares induzida par bisfosfonatos - revisão de literatura e relato de caso. RFO. 2011;16(2):229-233.

Aiex LS, Jimenez M VJ, Milena AP. Osteonecrose mandibular relacionada com bifosfonatos orais em paciente idosa polimedicada. Revista Brasileira de Medicina de Família e Comunidade. 2015;10(36):1-7.

Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F; American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031.

Heras Rincón I, Zubillaga Rodríguez I, Castrillo Tambay M, Montalvo Moreno JJ. Osteonecrosis of the jaws and bisphosphonates. Report of fifteen cases. Therapeutic recommendations. Med Oral Patol Oral Cir Bucal. 2007 Aug 1;12(4):E267-71.

Brozoski MA, Traina AA, Deboni, MCZ, Marques MM, Naclério-Homem MG. Osteonecrose maxilar associada ao uso de bisfosfonatos. Revista Brasileira de Reumatologia. 2012;2(52):260- 270.

Castilho LS, Lisboa SM, Costas LN, Vilaça EL, Souza ME, Silveira RR. Considerações sabre o paciente em tratamento com bisfosfonatos: o que todo cirurgiao-dentista precisa saber. Revista CROMG. 2013;14(1):19-24.

Graham R, Russell G. Bisphosphonates: Mode of Action and Pharmacology. Pediatrics. 2007;119:150-162.

Article Sidebar

Main Article Content